BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 5115764)

  • 1. [Pulmonary diffusion capacity in uremic patients undergoing maintenance hemodialytic treatment].
    Casucci G; Marchesi N; Buoncristiani U; Timio M; Sorbini CA
    Minerva Nefrol; 1971; 18(3):186-8. PubMed ID: 5115764
    [No Abstract]   [Full Text] [Related]  

  • 2. [The visual apparatus in chronic uremic patients during periodic hemodialytic treatment. 3. Changes in the caliber of the retinal vessels during hemodialysis].
    Sorice PS; Esposito E; Tretola L; Tufano L; Ambrosio A
    Rass Int Clin Ter; 1971 Aug; 51(15):948-52. PubMed ID: 5096694
    [No Abstract]   [Full Text] [Related]  

  • 3. [Study of the plasmatic renin and reno-medullin in chronic uremic patients during extracorporeal hemodialytic treatment].
    Ripa R; Alvisi R; Salzano S; Baggioni GF
    Minerva Med; 1970 Nov; 61(92):5219-33. PubMed ID: 4321215
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment of chronic uremic anemia in patients undergoing periodic extracorporeal dialysis with large doses of anabolic androgens].
    Pentangelo C; Mazza L; Scoppa F
    Rass Int Clin Ter; 1971 Oct; 51(20):1268-76. PubMed ID: 5137470
    [No Abstract]   [Full Text] [Related]  

  • 5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxalate behavior in patients undergoing periodic hemodialytic treatments].
    Zucchelli P; Fusaroli M; Sasdelli M; Stallone C
    Minerva Nefrol; 1970; 17(6):184-6. PubMed ID: 5516052
    [No Abstract]   [Full Text] [Related]  

  • 7. [Renal replacement therapy by hemodialysis: an overview].
    Jacobs C
    Nephrol Ther; 2009 Jul; 5(4):306-12. PubMed ID: 19481513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cimetidine in the therapy of secondary hyperparathyroidism in uremia with hemodialytic treatment].
    Antonucci F; Gropuzzo M; Messa P; Montanaro D; Adorati M; Paviotti G; Favazza A; Susanna F; Zilli M; Messa M
    Minerva Nefrol; 1983; 30(3):133-9. PubMed ID: 6646487
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hemodynamic evaluation of chronic uremic patients undergoing periodical hemodialytic treatment].
    Lojacono L; Butti A; Castagneto M; Cagossi M; Salerni B; Pigliucci GM; Alquati P
    Chir Patol Sper; 1970 Dec; 18(5):411-33. PubMed ID: 5525552
    [No Abstract]   [Full Text] [Related]  

  • 10. [The use of cimetidine in renal insufficiency under hemodialytic treatment].
    Antonucci F; Vezzadini P; Cascone C; Bertolone G; Bonora G; Gazzaniga A
    Minerva Nefrol; 1979; 26(3):379-84. PubMed ID: 262278
    [No Abstract]   [Full Text] [Related]  

  • 11. Quantified functions of the nervous system in uremic patients on maintenance dialysis.
    Teschan PE; Ginn HE; Walker PJ; Bourne JR; Fristoe M; Ward JW
    Trans Am Soc Artif Intern Organs; 1974; 20A():388-92. PubMed ID: 4450361
    [No Abstract]   [Full Text] [Related]  

  • 12. [Respiratory function abnormalities in uremic patients].
    Senatore M; Buemi M; Di Somma A; Sapio C; Gallo GC
    G Ital Nefrol; 2004; 21(1):29-33. PubMed ID: 15356844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diffusion of diphenylhydantoin across the cellophane membrane of the artificial kidney in a patient with uremia and epilepsy].
    Desjacques P
    Schweiz Rundsch Med Prax; 1972 Mar; 61(13):418-23. PubMed ID: 5020101
    [No Abstract]   [Full Text] [Related]  

  • 14. ["Clinical clearance" and "weekly clearance" of urea in periodical hemodialytic treatment].
    Ghezzi PM; Palanca R; Dutto A; Cento G
    Minerva Med; 1980 Oct; 71(39):2821-3. PubMed ID: 7432691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cholesterol-HDL and apoprotein A in a group of chronic uremic patients undergoing continuing hemodialytic treatment].
    Bergesio F; Ciuti R; Manfredi M; Frizzi V; Zerboni R
    Minerva Nefrol; 1983; 30(3):165-73. PubMed ID: 6646491
    [No Abstract]   [Full Text] [Related]  

  • 16. [Behavior of CK-MB in uremic patients undergoing periodic hemodialytic treatment. Considerations and proposals].
    Iacovoni P; Gaudio C; Fortezza P; Morosetti M; Meloni C; Gaspardone A; Valente A; Gioffré PA
    Clin Ter; 1985 Dec; 115(5):365-8. PubMed ID: 3830539
    [No Abstract]   [Full Text] [Related]  

  • 17. Uremia and adequate dialysis treatment.
    Acchiardo SR
    Semin Nephrol; 1994 May; 14(3):274-81. PubMed ID: 8036362
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma calcium fraction dynamics in uremic patients undergoing hemodialysis.
    Asad SN; Olmer AJ; Letteri JM
    Miner Electrolyte Metab; 1984; 10(5):333-6. PubMed ID: 6493162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uremic pruritus in the chronic renal failure patients.
    Chodorowska G; Wysokiński A; Chodorowski J
    Ann Univ Mariae Curie Sklodowska Med; 2004; 59(1):174-9. PubMed ID: 16145975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some aspects of gastric secretion in chronic uremic patients in periodic hemodialysis].
    Guarini G; Bruscagli GF; Cordova C; Santucci A; Cerulli N; Bruno S
    Minerva Nefrol; 1970; 17(6):181-3. PubMed ID: 5516051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.